Wild Biotech
Microbiome-derived Drug Discovery and Development Platform
Company Overview
Snapshot
Founded in April 2019 by Neta Raab, Ido Bachelet, and Gal Zanir, Wild Biotech operates with 1–10 employees. The company secured its seed funding in June 2019 from investors Marius Nacht and Tech.bio.
Business overview
Wild Biotech develops an AI-powered drug discovery platform focused on creating new medicines by leveraging an annotated metagenomic database of wild animal microbiota. The company utilizes artificial intelligence for de novo metagenome assembly, organizing and analyzing gut microbes based on associations with animal diets, activity, and lifespans. Wild Biotech's end-to-end process spans field exploration to clinical trials, with an initial focus on inflammatory, immune, and gastrointestinal diseases, currently having several lead compounds in the preclinical stage. It operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
Strategic signal
In March 2021, Wild Biotech garnered significant media attention from publications like FierceBiotech and BioWorld for its unique approach to drug discovery, which involves prospecting gut microbes from wild animals. This coverage highlights the company's innovative strategy in leveraging biodiversity for novel therapeutic compounds, signaling a potential paradigm shift in how new medicines are sourced and developed within the biotechnology and pharmaceutical industries.
Log in to access full profile ›Company Intelligence Q&A
- What is Wild Biotech's primary focus?
- Wild Biotech focuses on microbiome-derived drug discovery and development, utilizing an AI-powered platform to identify new medicines from wild animal microbiota.
- When was Wild Biotech founded?
- Wild Biotech was founded in April 2019.
- Who are the founders of Wild Biotech?
- Wild Biotech was founded by Neta Raab, Ido Bachelet, and Gal Zanir.
- What was a key milestone for Wild Biotech in June 2019?
- In June 2019, Wild Biotech secured seed funding from investors.
- What is the current operational status of Wild Biotech?
- Wild Biotech is currently non-active and ceased to operate in August 2026.